Inflammation in atherosclerosis: causal or casual? The need for randomized trials
Open Access
- 31 August 2003
- journal article
- editorial
- Published by Elsevier in American Heart Journal
- Vol. 146 (2) , 199-202
- https://doi.org/10.1016/s0002-8703(03)00226-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular EventsNew England Journal of Medicine, 2002
- Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2Science, 2002
- Immune Mechanisms in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- AtherosclerosisCell, 2001
- Expression of Cyclo-oxygenase-2 in Human Atherosclerotic Carotid ArteriesEuropean Journal of Vascular and Endovascular Surgery, 2000
- Nonsteroidal anti-inflammatory drugs after acute myocardial infarctionThe American Journal of Cardiology, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- The Yin and Yang of Oxidation in the Development of the Fatty StreakArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Suppression of NFκB activation and NFκB‐dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5‐lipoxygenaseJournal of Cellular Biochemistry, 1995